CVE-2018-18977

Name: CVE-2018-18977
Creator: NVD / NIST
Published: 2019-05-06T20:29:00.43+00:00
License: https://creativecommons.org/publicdomain/zero/1.0/

UnknownEPSS 1.58%

Last modified Jun 17, 2026

CVE-2018-18977 is a vulnerability of currently unknown severity. An issue was discovered in the Ascensia Contour NEXT ONE application for Android before 2019-01-15. An attacker may reverse engineer the codebase to extract sensitive data that contributes to the disclosure of medical information of patients utilizing the Ascensia platform. EPSS estimates a 1.58% chance of exploitation in the next 30 days.

Description

An issue was discovered in the Ascensia Contour NEXT ONE application for Android before 2019-01-15. An attacker may reverse engineer the codebase to extract sensitive data that contributes to the disclosure of medical information of patients utilizing the Ascensia platform. This occurs because of weak obfuscation.

Metrics

EPSS Probability

1.58%

72.4th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

CWE-200

Affected Software

Vendor	Product	Versions
Ascensia	Contour Diabetes	< 2.5.0

References

https://depthsecurity.com/blog/medical-exploitation-you-are-now-diabeticExploit, Third Party Advisory
https://depthsecurity.com/blog/medical-exploitation-you-are-now-diabeticExploit, Third Party Advisory

Timeline

Published: May 6, 2019
Last Modified: Jun 17, 2026
Status: Modified

Frequently Asked Questions

What is CVE-2018-18977?

How severe is CVE-2018-18977?

Severity scoring for CVE-2018-18977 is pending analysis. The EPSS model estimates a 1.58% probability of exploitation in the next 30 days.

How do I fix CVE-2018-18977?

Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2018-18977?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST